Biden’s Early Focus: Durable and Attainable Private Insurance
The focus of the nascent Biden administration has been on making private health insurance more durable, not deconstructing it.

The focus of the nascent Biden administration has been on making private health insurance more durable, not deconstructing it.

Waiver withdrawals provide a path forward for the Biden administration to end a grab bag of Trump-era Section 1115 waivers.

Insurers are increasingly crafting their coverage terms in ways that undermine a vital consumer protection.

This digital symposium explores recommendations for the Biden/Harris administration’s health policy agenda.

Senator Lisa Murkowski’s reintroduction of the Safe Step Act has revived the debate over the prudence of step therapy protocols.

A U.S. District Court recently halted the implementation of a dispute resolution rule for the 340B Drug Pricing Program.

Telehealth may be the missing key needed to shift the pendulum to providing sustainable, affordable, high-quality, and safe long-term care in the home.

Patients may face increased out-of-pocket drug costs as a result of a rule finalized by the Centers for Medicare & Medicaid Services in July 2020.
